SUBJECTS : Neurological Disorders | Neurolog
Therapeutic Advances in Neurological Disorders: 2023, vol: 16, issue:
- 1)- Sinah Engel, Luisa Klotz, Timo Wirth, Ann-Katrin Fleck, Geethanjali Pickert, Melanie Eschborn, Samia Kreuzburg, Valentina Curella, Stefan Bittner, Frauke Zipp, Detlef Schuppan, Felix Luessi. Attenuation of immune activation in patients with multiple sclerosis on a wheat-reduced diet: a pilot crossover trial. Therapeutic advances in neurological disorders. 2023, 16: 17562864231170928
Cited : 3Read More - 2)- Marco Puthenparampil, Marta Gaggiola, Alessandro Miscioscia, Valentina Annamaria Mauceri, Federica De Napoli, Giovanni Zanotelli, Mariagiulia Anglani, Margherita Nosadini, Stefano Sartori, Paola Perini, Francesca Rinaldi, Paolo Gallo. Alemtuzumab following natalizumab is more effective in adult-onset than paediatric-onset multiple sclerosis. Therapeutic advances in neurological disorders. 2023, 16: 17562864231177196Cited : 1Read More
- 3)- Karl Hartmann, Belal Neyazi, Klaus-Peter Stein, Aiden Haghikia, I Erol Sandalcioglu. Is the central nervous system enclosed by a mesothel? Therapeutic advances in neurological disorders. 2023, 16: 17562864231180335Cited : 1Read More
- 4)- Melanie Haidegger, Simon Lindenbeck, Edith Hofer, Christina Rodler, Robert Zweiker, Sabine Perl, Lukas Pirpamer, Markus Kneihsl, Simon Fandler-Höfler, Thomas Gattringer, Christian Enzinger, Reinhold Schmidt. Arterial stiffness and its influence on cerebral morphology and cognitive function. Therapeutic advances in neurological disorders. 2023, 16: 17562864231180715Cited : 2Read More
- 5)- Martin Šubert, Michal Novotný, Tereza Tykalová, Barbora Srpová, Lucie Friedová, Tomáš Uher, Dana Horáková, Jan Rusz. Lexical and syntactic deficits analyzed via automated natural language processing: the new monitoring tool in multiple sclerosis. Therapeutic advances in neurological disorders. 2023, 16: 17562864231180719Cited : 2Read More
- 6)- Antonios Bayas, Achim Berthele, Norbert Blank, Peter Dreger, Simon Faissner, Manuel A Friese, Lisa-Ann Gerdes, Oliver Martin Grauer, Vivien Häussler, Christoph Heesen, Dietlinde Janson, Mirjam Korporal-Kuhnke, Markus Kowarik, Nikolaus Kröger, Jan D Lünemann, Roland Martin, Uwe Meier, Sven Meuth, Paolo Muraro, Michael Platten, Lucas Schirmer, Klarissa Hanja Stürner, Jan Patrick Stellmann, Christof Scheid, Florian Then Bergh, Clemens Warnke, Brigitte Wildemann, Tjalf Ziemssen. Autologous haematopoietic stem cell transplantation for multiple sclerosis: a position paper and registry outline. Therapeutic advances in neurological disorders. 2023, 16: 17562864231180730Cited : 1Read More
- 7)- Ralf Gold, Michael Barnett, Andrew Chan, Huiyu Feng, Kazuo Fujihara, Gavin Giovannoni, Xavier Montalbán, Fu-Dong Shi, Mar Tintoré, Qun Xue, Chunsheng Yang, Hongyu Zhou. Clinical use of dimethyl fumarate in multiple sclerosis treatment: an update to include China, using a modified Delphi method. Therapeutic advances in neurological disorders. 2023, 16: 17562864231180734Cited : 2Read More
- 8)- Nicolas Mercure-Corriveau, Shuvro Roy, Chen Hu, Elizabeth P Crowe, Xianming Zhu, Danielle Obando, Eshan U Patel, Aaron A R Tobian, Yujie Wang, Evan M Bloch, Scott D Newsome. Therapeutic plasma exchange in the management of stiff person syndrome spectrum disorders: a case series and review of the literature. Therapeutic advances in neurological disorders. 2023, 16: 17562864231180736Cited : 2Read More
- 9)- Bitao Bu, Chao Quan, Wenyu Li, Qiuming Zeng, Ziyan Shi, Bo Chen, Lei Zhou, Luya Jin, Hongyu Zhou, Huan Yang. The effectiveness of teriflunomide in patients with multiple sclerosis in China: a real-world comparison to no DMT treatment in the first year after diagnosis. Therapeutic advances in neurological disorders. 2023, 16: 17562864231181170Cited : 2Read More
- 10)- Ichiro Nakashima, Jin Nakahara, Hiroaki Yokote, Yasuhiro Manabe, Kazumi Okamura, Kou Hasegawa, Kazuo Fujihara. Long-term safety and effectiveness of eculizumab in patients with aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder: a 2-year interim analysis of post-marketing surveillance in Japan. Therapeutic advances in neurological disorders. 2023, 16: 17562864231181177Cited : 5Read More
- 11)- Jiahao Meng, Zeya Yan, Jie Zhang, Wei Wang, Xinyu Tao, Feng Gu, Xingyu Yang, Tao Xue, Wanchun You, Zhouqing Chen, Zhong Wang, Gang Chen. Comparative efficacy and safety of various mechanical thrombectomy strategies for patients with acute ischemic stroke: a Bayesian network meta-analysis. Therapeutic advances in neurological disorders. 2023, 16: 17562864231181180Cited : 1Read More
- 12)- Md Nur Ahad Shah, Toshifumi Yokota. Cardiac therapies for Duchenne muscular dystrophy. Therapeutic advances in neurological disorders. 2023, 16: 17562864231182934Cited : 3Read More
- 13)- Diego Centonze, Maria Pia Amato, Vincenzo Brescia Morra, Eleonora Cocco, Nicola De Stefano, Claudio Gasperini, Paolo Gallo, Carlo Pozzilli, Maria Trojano, Massimo Filippi. Multiple sclerosis patients treated with cladribine tablets: expert opinion on practical management after year 4. Therapeutic advances in neurological disorders. 2023, 16: 17562864231183221Cited : 3Read More
- 14)- Aleksi J Sihvonen, Sini M Laakso, Olli Tynninen, Heikki Saaren-Seppälä, Mervi Löfberg. Complete remission of central nervous system manifestations of IgG4-related disease with rituximab - a case report. Therapeutic advances in neurological disorders. 2023, 16: 17562864231186091Cited : 0Read More
- 15)- Wenyan Shi, Hanlin Sun, Wei Peng, Ziyi Chen, Qun Wang, Weihong Lin, Meiping Ding, Hongbin Sun, Xiangqing Wang, Tiancheng Wang, Xuefeng Wang, Yonghong Liu, Yangmei Chen, Guoxing Zhu, Dong Zhou, Jinmei Li. Prevalence and risk factors of anxiety and depression in adult patients with epilepsy: a multicenter survey-based study. Therapeutic advances in neurological disorders. 2023, 16: 17562864231187194Cited : 1Read More
- 16)- Konstantinos Melanis, Maria-Ioanna Stefanou, Konstantinos M Themistoklis, Themistoklis Papasilekas. mTOR pathway - a potential therapeutic target in stroke. Therapeutic advances in neurological disorders. 2023, 16: 17562864231187770Cited : 2Read More
- 17)- Louisa Müller-Miny, Raoul Sauer, Andreas Schulte-Mecklenbeck, Catharina C Gross, Stjepana Kovac, Matthias Schilling, Carolin Beuker, Heinz Wiendl, Gerd Meyer Zu Hörste. Contactin-associated protein 2 autoantibodies can be associated with multifocal motor-like neuropathy: a case report. Therapeutic advances in neurological disorders. 2023, 16: 17562864231189323Cited : 0Read More
- 18)- Isabel Sánchez-Vera, Esther Escudero, Úrsula Muñoz, María C Sádaba. IgM to phosphatidylcholine in multiple sclerosis patients: from the diagnosis to the treatment. Therapeutic advances in neurological disorders. 2023, 16: 17562864231189919Cited : 1Read More
- 19)- Barbara Ladisich, Stefan Rampp, Eugen Trinka, Nathan Weisz, Christoph Schwartz, Theo Kraus, Camillo Sherif, Franz Marhold, Gianpaolo Demarchi. Network topology in brain tumor patients with and without structural epilepsy: a prospective MEG study. Therapeutic advances in neurological disorders. 2023, 16: 17562864231190298Cited : 0Read More
- 20)- Suraj Muley, Said R Beydoun. Impact of the updated chronic inflammatory demyelinating polyneuropathy guideline on everyday clinical practice. Therapeutic advances in neurological disorders. 2023, 16: 17562864231190549Cited : 0Read More
- 21)- Graeme J Sills. Pharmacological diversity amongst approved and emerging antiseizure medications for the treatment of developmental and epileptic encephalopathies. Therapeutic advances in neurological disorders. 2023, 16: 17562864231191000Cited : 3Read More
- 22)- Carlos Casasnovas, Laura Lladó, Cristina Borrachero, Patricia Valentina Pérez-Santamaría, Francisco Muñoz-Beamud, Inés Asunción Losada-López, Maria Carme Baliellas-Comellas, Juan González-Moreno. A narrative review and expert recommendations on the assessment of the clinical manifestations, follow-up, and management of post-OLT patients with ATTRv amyloidosis. Therapeutic advances in neurological disorders. 2023, 16: 17562864231191590Cited : 1Read More
- 23)- Matthias Grothe, David Ellenberger, Paulus S Rommer, Alexander Stahmann, Uwe K Zettl. Epileptic seizures at multiple sclerosis onset and their role in disease progression. Therapeutic advances in neurological disorders. 2023, 16: 17562864231192826Cited : 0Read More
- 24)- Eugen Trinka, Rodrigo Rocamora, João Chaves, Mathias J Koepp, Stephan Rüegg, Martin Holtkamp, Joana Moreira, Miguel M Fonseca, Guillermo Castilla-Fernández, Fábio Ikedo. Lipid profile with eslicarbazepine acetate and carbamazepine monotherapy in adult patients with newly diagnosed focal seizures: analysis of a phase III trial and open-label extension study. Therapeutic advances in neurological disorders. 2023, 16: 17562864231193530Cited : 1Read More
- 25)- Meng Wang, Caiyun Liu, Meijuan Zou, Zixuan Niu, Jie Zhu, Tao Jin. Recent progress in epidemiology, clinical features, and therapy of multiple sclerosis in China. Therapeutic advances in neurological disorders. 2023, 16: 17562864231193816Cited : 2Read More
- 26)- Marinos C Dalakas. Objectivity, practicality, and significance of practice guidelines for the practicing neurologists: What we learnt from consensus criteria in CIDP, Myasthenia Gravis and Inflammatory Myopathies. Therapeutic advances in neurological disorders. 2023, 16: 17562864231194821Cited : 2Read More
- 27)- Alasdair J Coles, Anat Achiron, Anthony Traboulsee, Barry A Singer, Carlo Pozzilli, Celia Oreja-Guevara, Gavin Giovannoni, Giancarlo Comi, Mark S Freedman, Tjalf Ziemssen, Debora Shiota, Andreea M Rawlings, Alana T Wong, Magdalena Chirieac, Xavier Montalban. Safety and efficacy with alemtuzumab over 13 years in relapsing-remitting multiple sclerosis: final results from the open-label TOPAZ study. Therapeutic advances in neurological disorders. 2023, 16: 17562864231194823Cited : 1Read More
- 28)- Clara Grazia Chisari, Joe Guadagno, Peyman Adjamian, Carlos Vila Silvan, Teresa Greco, Makarand Bagul, Francesco Patti. A evaluation of the shift in spasticity category in individuals with multiple sclerosis-related spasticity treated with nabiximols. Therapeutic advances in neurological disorders. 2023, 16: 17562864231195513Cited : 0Read More
- 29)- Anke Salmen, Robert Hoepner, Vinzenz Fleischer, Milena Heldt, Barbara Gisevius, Jeremias Motte, Klemens Ruprecht, Ruth Schneider, Anna Lena Fisse, Thomas Grüter, Carsten Lukas, Achim Berthele, Katrin Giglhuber, Martina Flaskamp, Mark Mühlau, Jan Kirschke, Stefan Bittner, Sergiu Groppa, Felix Lüssi, Antonios Bayas, Sven Meuth, Cristoph Heesen, Corinna Trebst, Brigitte Wildemann, Florian Then Bergh, Gisela Antony, Tania Kümpfel, Friedemann Paul, Sandra Nischwitz, Hayrettin Tumani, Uwe Zettl, Bernh. Factors associated with depressive mood at the onset of multiple sclerosis - an analysis of 781 patients of the German NationMS cohort. Therapeutic advances in neurological disorders. 2023, 16: 17562864231197309Cited : 1Read More
- 30)- Shaddy El-Masri, Matthew Wilson, Jonathan Goh, Paul Sanfilippo, Anthony Fok, Thomas Hardy, Rahul Chakrabarti, Anneke Van Der Walt. A 20-year multicentre retrospective review of optic nerve sheath fenestration outcomes. Therapeutic advances in neurological disorders. 2023, 16: 17562864231197994Cited : 1Read More
- 31)- Richard Nicholas, Jeff Rodgers, James Witts, Annalaura Lerede, Tim Friede, Jan Hillert, Lars Forsberg, Anna Glaser, Ali Manouchehrinia, Ryan Ramanujam, Tim Spelman, Pernilla Klyve, Jiri Drahota, Dana Horakova, Hanna Joensen, Luigi Pontieri, Melinda Magyari, David Ellenberger, Alexander Stahmann, Helmut Butzkueven, Anneke Van Der Walt, Vladimir Bezlyak, Carol Lines, Rod Middleton. The impact of healthcare systems on the clinical diagnosis and disease-modifying treatment usage in relapse-onset multiple sclerosis: a real-world perspective in five registries across Europe. Therapeutic advances in neurological disorders. 2023, 16: 17562864231198963Cited : 2Read More
- 32)- Kimberley Allen-Philbey, Stefania De Trane, Amy MacDougall, Ashok Adams, Lucia Bianchi, Thomas Campion, Gavin Giovannoni, Sharmilee Gnanapavan, David W Holden, Monica Marta, Joela Mathews, Benjamin P Turner, David Baker, Klaus Schmierer. Disease activity 4.5 years after starting cladribine: experience in 264 patients with multiple sclerosis. Therapeutic advances in neurological disorders. 2023, 16: 17562864231200627Cited : 1Read More
- 33)- Luigi G Remore, Ziad Rifi, Hiroki Nariai, Dawn S Eliashiv, Aria Fallah, Benjamin D Edmonds, Joyce H Matsumoto, Noriko Salamon, Meskerem Tolossa, Wexin Wei, Marco Locatelli, Evangelia C Tsolaki, Ausaf A Bari. Structural connections of the centromedian nucleus of thalamus and their relevance for neuromodulation in generalized drug-resistant epilepsy: insight from a tractography study. Therapeutic advances in neurological disorders. 2023, 16: 17562864231202064Cited : 2Read More
- 34)- Ioannis N Petropoulos, Karen John, Fatima Al-Shibani, Georgios Ponirakis, Adnan Khan, Hoda Gad, Ziyad R Mahfoud, Heba Altarawneh, Muhammad Hassan Rehman, Dhabia Al-Merekhi, Pooja George, Faiza Ibrahim, Reny Francis, Beatriz Canibano, Dirk Deleu, Ahmed El-Sotouhy, Surjith Vattoth, Mark Stettner, Ahmed Own, Ashfaq Shuaib, Naveed Akhtar, Saadat Kamran, Rayaz A Malik. Corneal immune cells as a biomarker of inflammation in multiple sclerosis: a longitudinal study. Therapeutic advances in neurological disorders. 2023, 16: 17562864231204974Cited : 0Read More
- 35)- Inès Bekkour, Edouard Courtin, Cécile Dulau-Metras, Pierre Duffau, Laurent Kremer, Guillaume Mathey. Defining the course of neurosarcoidosis according to presentation at onset and disease modifying treatment: a cohort study of 84 patients. Therapeutic advances in neurological disorders. 2023, 16: 17562864231205954Cited : 0Read More
- 36)- Chun-Wei Chang, Wei-En Johnny Tseng, Wey-Ran Lin, Po-Chuan Ko, Chun-Jing Liu, Siew-Na Lim. Optimizing treatment persistence in epilepsy: a comparative analysis of combined antiseizure medications with different mechanisms of action. Therapeutic advances in neurological disorders. 2023, 16: 17562864231207161Cited : 0Read More
- 37)- Laura Schnetzer, Jürgen Steinbacher, Gerhard Bauer, Alexander Baden Kunz, Jürgen Bergmann, Martin Kronbichler, Eugen Trinka, Mark McCoy. The vascular locked-in and locked-in-plus syndrome: A retrospective case series. Therapeutic advances in neurological disorders. 2023, 16: 17562864231207272Cited : 0Read More
- 38)- Woon Hyung Chae, Annika Vössing, Yan Li, Cornelius Deuschl, Lennart Steffen Milles, Jordi Kühne Escolà, Anika Hüsing, Marvin Darkwah Oppong, Philipp Dammann, Martin Glas, Michael Forsting, Christoph Kleinschnitz, Martin Köhrmann, Benedikt Frank. Treatment of acute ischemic stroke in patients with active malignancy: insight from a comprehensive stroke center. Therapeutic advances in neurological disorders. 2023, 16: 17562864231207508Cited : 1Read More
- 39)- Meredith A Bryarly, Michael A Rubin, Olaf Stuve. Perspective: Industry-patient relationships for the promotion of pharmaceutical agents. Therapeutic advances in neurological disorders. 2023, 16: 17562864231207560Cited : 0Read More
- 40)- Shengyi Liu, Zihua He, Jinmei Li. Long-term efficacy and adverse effects of cannabidiol in adjuvant treatment of drug-resistant epilepsy: a systematic review and meta-analysis. Therapeutic advances in neurological disorders. 2023, 16: 17562864231207755Cited : 0Read More
- 41)- Jan Kassubek, Fabrizio Stocchi, Ernest Balaguer Martinez, Rajesh Pahwa, William Ondo, Yi Zhang, Alyssa Bowling, Eric Pappert, Stuart Isaacson, Stacy Wu, . Feasibility of home dose optimization of apomorphine sublingual film in Parkinson's disease patients with OFF episodes: results from the dose-optimization phase of an open-label, randomized crossover study. Therapeutic advances in neurological disorders. 2023, 16: 17562864231209240Cited : 2Read More
- 42)- Valerie E Teschner, Ann-Katrin Fleck, Carolin Walter, Anna-Sophie Schwarze, Melanie Eschborn, Timo Wirth, Olga V Steinberg, Andreas Schulte-Mecklenbeck, I-Na Lu, Marisol Herrera-Rivero, Claudia Janoschka, Jan D Lünemann, Nicholas Schwab, Gerd Meyer Zu Hörste, Julian Varghese, Catharina C Gross, Refik Pul, Christoph Kleinschnitz, Simone Mader, Edgar Meinl, Monika Stoll, Heinz Wiendl, Luisa Klotz. Single-cell profiling reveals preferential reduction of memory B cell subsets in cladribine patients that correlates with treatment response. Therapeutic advances in neurological disorders. 2023, 16: 17562864231211077Cited : 1Read More
- 43)- Jiajie Mo, Wenyu Dong, Lin Sang, Zhong Zheng, Qiang Guo, Xiuming Zhou, Wenjing Zhou, Haixiang Wang, Xianghong Meng, Yi Yao, Fengpeng Wang, Wenhan Hu, Kai Zhang, Xiaoqiu Shao. Multimodal imaging-based diagnostic approach for MRI-negative posterior cortex epilepsy. Therapeutic advances in neurological disorders. 2023, 16: 17562864231212254Cited : 0Read More
- 44)- Heinz Wiendl, Angela Abicht, Andrew Chan, Adela Della Marina, Tim Hagenacker, Khosro Hekmat, Sarah Hoffmann, Hans-Stefan Hoffmann, Sebastian Jander, Christian Keller, Alexander Marx, Arthur Melms, Nico Melzer, Wolfgang Müller-Felber, Marc Pawlitzki, Jens-Carsten Rückert, Christiane Schneider-Gold, Benedikt Schoser, Bettina Schreiner, Michael Schroeter, Bettina Schubert, Jörn-Peter Sieb, Fritz Zimprich, Andreas Meisel. Guideline for the management of myasthenic syndromes. Therapeutic advances in neurological disorders. 2023, 16: 17562864231213240Cited : 6Read More
- 45)- Todd D Rozen, Zlatko Devcic, Andrew R Lewis, Sukhwinder J S Sandhu, Young Erben, Beau B Toskich. A secondary daily persistent headache from onset with underlying nutcracker physiology and spinal epidural venous congestion: case series with lumbar vein embolization as a therapeutic approach. Therapeutic advances in neurological disorders. 2023, 16: 17562864231213243Cited : 0Read More
- 46)- Juliane Klehmet, Yvonne Begus-Nahrmann, Kirsi Taipale, Gabriele Niemczyk, Karin Rehberg-Weber. Pregnancy outcomes in female multiple sclerosis patients exposed to intramuscular interferon beta-1a or peginterferon beta-1a reported in a German Patient Support Programme - results from the non-interventional post-authorization safety study PRIMA. Therapeutic advances in neurological disorders. 2023, 16: 17562864231214041Cited : 0Read More
- 47)- Marinos C Dalakas, Jessica Yi. Late-onset stiff-person syndrome: challenges in diagnosis and management. Therapeutic advances in neurological disorders. 2023, 16: 17562864231214315Cited : 0Read More
- 48)- Dongmei Wang, Meirong Li, Yue Pan, Zhenzhou Lin, Zhong Ji, Xiaomei Zhang, Miaoqin Tan, Suyue Pan, Yongming Wu, Shengnan Wang. Risk factors for super-refractory and mortality in generalized convulsive status epilepticus: a 10-year retrospective cohort study. Therapeutic advances in neurological disorders. 2023, 16: 17562864231214846Cited : 0Read More
- 49)- Chunjiang Wang, Weijin Fang, Wei Sun, Shaoli Zhao, Liping Peng. Clinical characteristics, treatments, and outcomes of interferon-beta-induced thrombotic microangiopathy: a literature-based retrospective analysis. Therapeutic advances in neurological disorders. 2023, 16: 17562864231216634Cited : 0Read More
- 50)- Jeremy Molad, Hen Hallevi, Estelle Seyman, Einor Ben-Assayag, Tali Jonas-Kimchi, Udi Sadeh, Ofer Rotschild, Naaem Simaan, Anat Horev, Jose Cohen, Ronen R Leker, Asaf Honig. The pivotal role of timing of intravenous thrombolysis bridging treatment prior to endovascular thrombectomy. Therapeutic advances in neurological disorders. 2023, 16: 17562864231216637Cited : 0Read More
